Replies to post #162556 on NorthWest Biotherapeutics Inc (NWBO)

[flipper44]

Certain things have to happen for LP to access and/or collect on the potentially exercisable options/warrants she controls. If she could, she’s up to about 110 million or so, IMO.

Remember, some of her shares accelerate fully for certain events like sale of company and/or filing a BLA and/or trial success of phase II or phase iii trial.

Some shares don’t become available unless vote to authorize share increase.

Some shares don’t become available unless she collects on the loan.

A “win” based on one of the above events would likely lead to unlocking all but 17 million potential shares. This is all my opinion.

They would be considered closely held shares, and might not add to the float a great deal unless there was a sale of the company.

[sentiment_stocks]

I "fed" myself some breakfast, and then decided (out of curiosity) to try to figure out the answer to your question.

This is what I've come up. Anyone feel free to "feed" me your corrections.

The shares LP actually holds are as follows:

Currently holding shares
1,572,200 - LP shares
804,145 - Toucan Capital Fund III shares
2,211,784 - Toucan Partners LLC shares

4,588,129 common

AND

2,941,176 preferred Series A
(can vote up to 29,411,760 common so long as under shelf of 450 million, and convert to same number of common shares when they are available)

If all her options, warrants were exercised and recent $4 million loan converted to pref shares and warrants, and subsequently all preferred converted, she would have:


131,424,734 shares

This could be LP's theme song.

sans the profanity, and with lyrics (in case China wants to sing along, lol).

Breakdown for LP as follows:

Currently holding shares
1,572,200 - LP shares
804,145 - Toucan Capital Fund III shares
2,211,784 - Toucan Partners LLC shares

= 4,588,129

Currently exercisable options
592,500 - LP options
1,732,246 - Toucan Capital Fund III warrants
1,505,739 - Toucan Partners LLC warrants

= 3,830,485

Employee Options (upon availability of shares)
Linda Powers 29,400,000

= 29,400,000

Preferred Shares (Series A)
2,941,176 (convertible to 29,411,760 when shares available)

Warrants (D-1)
29,411,760 (convertible when shares available)

= 58,823,520

$4 million loan (Series B)
1,739,130 (convertible to 17,391,300 when shares available and loan converted to shares)

Warrants (D-2)
8,695,652 (granted when loan was done)

8,695,652 (granted if and when $4 million loan, or parts of loan, are converted)

= 34,782,600

Total potential LP shares:
131,424,734
IMO



Cognate has, IMO:

13,684,294 - Cognate shares

11,557,929 - Cognate warrants

5,200,865 - Cognate pref shares (series B) convertible to 52,008,650

52,008,650 - Cognate warrants (series D-2)

All converted, Cognate's share count would equal: 129,259,523 shares